Extending molecular responeses with Nilotinib in newly diagnosed chronic myeloid leukemia (CML) patients in chronic phase (ENESTxtnd)
عنوان الدراسة
Extending molecular responeses with Nilotinib in newly diagnosed chronic myeloid leukemia (CML) patients in chronic phase (ENESTxtnd)
داعم الدراسة
Novartis
دواء الدراسة
Nilotinib
رقم بروتوكول الدراسة
CAMN107E2401
حالة الدراسة
Completed
موقع الدراسة
KFSH
مرحلة الدراسة
3b
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.